GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Omega Alpha SPAC (NAS:OMEG) » Definitions » Common Stock

Omega Alpha SPAC (Omega Alpha SPAC) Common Stock : $138.71 Mil (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Omega Alpha SPAC Common Stock?

Omega Alpha SPAC's quarterly common stock increased from Mar. 2022 ($138.00 Mil) to Jun. 2022 ($138.10 Mil) and increased from Jun. 2022 ($138.10 Mil) to Sep. 2022 ($138.71 Mil).

Omega Alpha SPAC's annual common stock stayed the same from . 20 ($0.00 Mil) to Dec. 2020 ($0.00 Mil) but then increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($138.00 Mil).


Omega Alpha SPAC Common Stock Historical Data

The historical data trend for Omega Alpha SPAC's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omega Alpha SPAC Common Stock Chart

Omega Alpha SPAC Annual Data
Trend Dec20 Dec21
Common Stock
- 138.00

Omega Alpha SPAC Quarterly Data
Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Common Stock Get a 7-Day Free Trial 138.00 138.00 138.00 138.10 138.71

Omega Alpha SPAC Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Omega Alpha SPAC (Omega Alpha SPAC) Business Description

Traded in Other Exchanges
N/A
Address
888 Boylston Street, Suite 1111, Boston, MA, USA, 02199
Website
Omega Alpha SPAC is a blank check company.
Executives
Otello Stampacchia director, 10 percent owner, officer: Chief Executive Officer 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Alpha Management Omega 10 percent owner 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02119
Joseph P Slattery director C/O TRANSENTERIX, INC., 635 DAVIS DRIVE, SUITE 300, MORRISVILLE NC 27560
Martin Babler director C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139
Daniel Lynch director
Vincent Ossipow officer: Chief Scientific Officer CH. DES VIGNES 1, COMMUGNY V8 1291
Van De Winkel Jan director C/O HOOKIPA PHARMA INC., 430 EAST 29TH STREET 14TH FLOOR, NEW YORK NY 10016
Omega Fund Vi, L.p. 10 percent owner 888 BOYLSTON ST., SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp Manager, Ltd. 10 percent owner 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Omega Fund Vi Gp, L.p. 10 percent owner 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199
Michelle Doig director, officer: President C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Francesco Draetta officer: Chief Financial Officer C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET SUITE 1111, BOSTON MA 02199
Alexandra Pearsall 10 percent owner C/O OMEGA ALPHA SPAC, 888 BOYLSTON STREET, SUITE 1111, BOSTON MA 02199

Omega Alpha SPAC (Omega Alpha SPAC) Headlines

From GuruFocus

Omega Alpha SPAC Announces Pricing of Its Initial Public Offering

By Business Wire Business Wire 01-07-2021

Omega Alpha Spac (OMEG) CEO Otello Stampacchia Bought $5 million of Shares

By GuruFocus Research GuruFocus Editor 01-14-2021